Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Oral Biologics & Biosimilar Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
AstraZeneca plc
Novartis
Eli Lilly and Co
Rani Therapeutics
By Type:
Proteins & Peptides
Others
Vaccines
Monoclonal Antibodies
By Application:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Oral Biologics & Biosimilar Drugs Market Overview 2018-2029
-
1.1 China Oral Biologics & Biosimilar Drugs Industry Development Overview
-
1.2 China Oral Biologics & Biosimilar Drugs Industry Development History
-
1.3 China Oral Biologics & Biosimilar Drugs Industry Market Size (2018-2029)
-
1.4 China Oral Biologics & Biosimilar Drugs Market Analysis by Type from Production Side
-
1.4.1 China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Proteins & Peptides (2018-2029)
-
1.4.2 China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
1.4.4 China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
1.5 China Oral Biologics & Biosimilar Drugs Market Analysis by Application from Consumption End
-
1.5.1 China Oral Biologics & Biosimilar Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.2 China Oral Biologics & Biosimilar Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
1.5.3 China Oral Biologics & Biosimilar Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
1.6 China Oral Biologics & Biosimilar Drugs Market Analysis by Region
-
1.6.1 North China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China Oral Biologics & Biosimilar Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Oral Biologics & Biosimilar Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China Oral Biologics & Biosimilar Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China Oral Biologics & Biosimilar Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Oral Biologics & Biosimilar Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Oral Biologics & Biosimilar Drugs Industry Development
Chapter 3 Oral Biologics & Biosimilar DrugsIndustry Chain Analysis
-
3.1 Oral Biologics & Biosimilar Drugs Industry Chain
-
3.2 Oral Biologics & Biosimilar Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Oral Biologics & Biosimilar Drugs Market
-
3.3 Oral Biologics & Biosimilar Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Oral Biologics & Biosimilar Drugs Market
Chapter 4 China Oral Biologics & Biosimilar Drugs Market, by Type
-
4.1 China Oral Biologics & Biosimilar Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Oral Biologics & Biosimilar Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Proteins & Peptides
-
4.5.2 China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Others
-
4.5.3 China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Vaccines
-
4.5.4 China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Monoclonal Antibodies
Chapter 5 China Oral Biologics & Biosimilar Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Oral Biologics & Biosimilar Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate, by Application
-
5.5.1 China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate of Hospital Pharmacies
-
5.5.2 China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate of Online Pharmacies
-
5.5.3 China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate of Retail Pharmacies
Chapter 6 China Oral Biologics & Biosimilar Drugs Market, by Region
-
6.1 China Oral Biologics & Biosimilar Drugs Production Volume and Production Value, by Region
-
6.2 China Oral Biologics & Biosimilar Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China Oral Biologics & Biosimilar Drugs Market Analysis
-
7.1 North China Oral Biologics & Biosimilar Drugs Market, by Type
-
7.2 North China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 8 Central China Oral Biologics & Biosimilar Drugs Market Analysis
-
8.1 Central China Oral Biologics & Biosimilar Drugs Market, by Type
-
8.2 Central China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 9 South China Oral Biologics & Biosimilar Drugs Market Analysis
-
9.1 South China Oral Biologics & Biosimilar Drugs Market, by Type
-
9.2 South China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 10 East China Oral Biologics & Biosimilar Drugs Market Analysis
-
10.1 East China Oral Biologics & Biosimilar Drugs Market, by Type
-
10.2 East China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 11 Northeast China Oral Biologics & Biosimilar Drugs Market Analysis
-
11.1 Northeast China Oral Biologics & Biosimilar Drugs Market, by Type
-
11.2 Northeast China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 12 Southwest China Oral Biologics & Biosimilar Drugs Market Analysis
-
12.1 Southwest China Oral Biologics & Biosimilar Drugs Market, by Type
-
12.2 Southwest China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 13 Northwest China Oral Biologics & Biosimilar Drugs Market Analysis
-
13.1 Northwest China Oral Biologics & Biosimilar Drugs Market, by Type
-
13.2 Northwest China Oral Biologics & Biosimilar Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 AstraZeneca plc
-
14.1.1 AstraZeneca plc Company Profile
-
14.1.2 AstraZeneca plc Oral Biologics & Biosimilar Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis
-
14.2.1 Novartis Company Profile
-
14.2.2 Novartis Oral Biologics & Biosimilar Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Eli Lilly and Co
-
14.3.1 Eli Lilly and Co Company Profile
-
14.3.2 Eli Lilly and Co Oral Biologics & Biosimilar Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Rani Therapeutics
-
14.4.1 Rani Therapeutics Company Profile
-
14.4.2 Rani Therapeutics Oral Biologics & Biosimilar Drugs Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Oral Biologics & Biosimilar Drugs Industry Research Conclusions
-
15.2 Oral Biologics & Biosimilar Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Oral Biologics & Biosimilar Drugs Industry Market Size (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Proteins & Peptides (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Vaccines (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume, Production Value and Growth Rate of Monoclonal Antibodies (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Sales Volume, Sales Value and Growth Rate of Online Pharmacies (2018-2029)
-
Figure China Oral Biologics & Biosimilar Drugs Sales Volume, Sales Value and Growth Rate of Retail Pharmacies (2018-2029)
-
Figure North China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate from 2018-2029
-
Figure Oral Biologics & Biosimilar Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Oral Biologics & Biosimilar Drugs Market Share by Type in 2018
-
Figure China Oral Biologics & Biosimilar Drugs Market Share by Type in 2023
-
Figure China Oral Biologics & Biosimilar Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Proteins & Peptides (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Vaccines (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume and Growth Rate of Monoclonal Antibodies (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Market Share by Application in 2018
-
Figure China Oral Biologics & Biosimilar Drugs Market Share by Application in 2023
-
Figure China Oral Biologics & Biosimilar Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate of Online Pharmacies (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Market Size and Growth Rate of Retail Pharmacies (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Production Volume by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Production Volume Share by Region (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Production Volume Share by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Production Value by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Production Value Share by Region (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Production Value Share by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Sales Volume by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Sales Volume Share by Region (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Sales Volume Share by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Sales Value by Region (2018-2023)
-
Table China Oral Biologics & Biosimilar Drugs Sales Value Share by Region (2018-2023)
-
Figure China Oral Biologics & Biosimilar Drugs Sales Value Share by Region (2018-2023)
-
Table North China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table North China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure North China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table North China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table North China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table Central China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table Central China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table Central China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table South China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table South China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure South China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table South China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table South China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table East China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table East China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure East China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table East China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table East China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table Northeast China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table Southwest China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China Oral Biologics & Biosimilar Drugs Production Volume by Type (2018-2023)
-
Table Northwest China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China Oral Biologics & Biosimilar Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China Oral Biologics & Biosimilar Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Oral Biologics & Biosimilar Drugs Sales Volume Share by Application (2018-2023)
-
Table AstraZeneca plc Company Profile
-
Table AstraZeneca plc Oral Biologics & Biosimilar Drugs Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Oral Biologics & Biosimilar Drugs Revenue, Price and Gross (2018-2023)
-
Table Eli Lilly and Co Company Profile
-
Table Eli Lilly and Co Oral Biologics & Biosimilar Drugs Revenue, Price and Gross (2018-2023)
-
Table Rani Therapeutics Company Profile
-
Table Rani Therapeutics Oral Biologics & Biosimilar Drugs Revenue, Price and Gross (2018-2023)
-
